NCT02777476进行中（未招募）不适用
Clinical Performance of B-Lite® Light Weight Breast Implant
G&G Biotechnology Ltd.3 个研究点 分布在 3 个国家目标入组 120 人开始时间: 2016年10月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
- 试验地点
- 3
- 主要终点
- Changes in breast size measurements
研究概览
简要总结
This is a post-marketing study for B-Lite® implants that carry the EC certificate for marketing in Europe and AMAR certificate for marketing in Israel. To date, thousands of implants have already been implanted in women. The study is open for primary augmentation patients only. All surgeries will be performed as per standard practice at the given study site. No parallel surgical procedures will be performed at the same session.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Genetic women between the ages of 18 and 60 seeking primary breast augmentation
- •Patient is eligible to undergo MRI (i.e., no implanted metal or metal devices, no history of severe claustrophobia)
- •Patient provides signed informed consent
- •Patient agrees to comply with the study protocol and complete all required follow up visits, including to undergo MRI
- •Patient agrees to return the device to the Sponsor should the implant have to be explanted
- •The patient has realistic expectations of surgical results after discussion with investigator and is an acceptable candidate for breast augmentation.
排除标准
- •Patients with active infection anywhere in their body
- •Patient is pregnant or nursing at the time of recruitment, or has been in the 6 months preceding recruitment date, or not willing to use reliable means of contraception during the first year after surgery
- •Patient was implanted with any silicone implant other than breast implants (e.g., silicone artificial joints or facial implants)
- •Patient breast tissue is clinically incompatible for the procedure (e.g., tissue damage resulting from radiation, insufficient tissue coverage or compromised vascularity)
- •Patient has a condition, or is under treatment for any condition, which, in the opinion of the investigator and/or consulting physician(s), may constitute an unwarranted surgical risk (e.g., unstable cardiac or pulmonary problems, possible allergies and/or extraordinary immune response to implant)
- •The patient has a history of mental instability and/or history of pharmaceutical psychiatric treatment
- •Patient unable to understand the scope of the study and/or surgery
- •The patient has any disease, including uncontrolled diabetes (e.g., HbA1c > 8%), that is clinically known to impact wound healing ability
- •Patient has existing costal injuries
- •Patient has abscesses, malignant tumors (cancer or recurrent metastases), clinically relevant cysts or advanced fibrotic disease or patient with BIRAD ≥3
- •Are not willing to undergo further surgery for revision, if medically required
- •The patient has a confirmed rheumatic disease or syndrome (e.g., SLE, Sjogren's syndrome, scleroderma, polymyositis or any connective tissue disorder, rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, any other inflammatory arthritis, fibromyalgia or chronic fatigue syndrome)
- •The patient has a severe breast and upper trunk deformity
- •The patient participated in an investigational trial within 90 days of enrollment
- •The patient has undergone an invasive medical procedure within 90 days of enrollment.
- •Aesthetic addiction, drug abuse, alcohol abuse
结局指标
主要结局
Changes in breast size measurements
时间窗: 3 years
Changes in bra size measurements
时间窗: 3 years
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
已完成
2 期
Assessment of Safety & Efficacy of Light Weight Breast ImplantBreast ImplantsNCT01874652Bnai Zion Medical Center50
已完成
不适用
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation ProceduresCarcinoma, HepatocellularMetastatic Liver CancerNCT04970212Techsomed Medical Technologies LTD65
进行中（未招募）
不适用
RCT of BLT Implants Used for Immediate vs Early Placement, Restored With Ceramic Crowns on Titanium Bonding Bases.Tooth LossDental Implant, Single-toothNCT05079542University of Geneva, Switzerland60
招募中
不适用
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.Esophageal NeoplasmsHead and Neck NeoplasmsGastrointestinal NeoplasmsDigestive System DiseasesDigestive System NeoplasmsEsophageal DiseasesNeoplasms by SiteGastrointestinal DiseasesNeoplasmsNCT06365866Taipei Veterans General Hospital, Taiwan20
招募中
不适用
LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA ImplantChronic Low-back PainHerniated DiscLumbar Canal StenosisDegenerative Disc DiseaseNCT04631133BACKBONE136